Cutacort cream
Broad-spectrum antimycotic with a corticoid additive Composition:
1 gm Cutacort Cream contains 10 mg isoconazole nitrate and 1mg diflucortolone valerate in an easy to remove low fat base (o/w emulsion). Properties:
Isoconazole nitrate is for use in the treatment of superficial fungal diseases of the skin.
It displays a very broad spectrum of antimicrobial action. It is effective against dermatophytes , yeasts, yeast-like fungi (including the causative organism of pityriasis versicolor) and moulds, as well as against the causative organism of erythrasma and against gram -positive bacteria.
Diflucortolone valerate suppresses inflammation in inflammatory and allergic skin conditions and alleviates subjective complaints such as itching, burning and pain. Indications & usage:
Initial or intermittent treatment of those superficial fungal infections of the skin
which are accompanied by highly inflammatory or eczematous skin conditions, e.g. in the region of the hands, the interdigital spaces of the feet, and in the inguinal and genital regions. Contra-indications:
Tuberculous or syphilitic processes in the area to be treated; virus diseases( e.g. vaccinia , chickenpox , shingles).
As a general rule, topical preparations containing corticoids should not be applied during the first trimester of pregnancy , In particular application to large areas of the body or for prolonged periods must be avoided . Side effects:
In general, Cutacort is tolerated very well, signs of irritation or allergic reactions of the skin can occur in rare cases. The following reactions may occur when Cutacort is applied to large areas of the body (about 10% or more) and/or for long periods of time (more than 4 weeks):
local concomitant symptoms such as atrophy of the skin, telangiectasia, striae, acne form changes of the skin perioral dermatitis, increased growth of body hair
( hypertrichosis), and systemic effects of the corticoid due to absorption.
Side effects cannot be excluded in neonates whose mothers have been treated extensively or for a prolonged period of time ,during pregnancy or while lactating
( for example, reduced adrenocortical function , when applied during the last weeks of pregnancy). Warnings & precautions:
Additional specific therapy may be required in mixed bacterial infections caused by Gram -negative organisms.
Cutacort should not be allowed to come into contact with the eyes when being applied to the face.
If roseola or perioral dermatitis is present, Cutacort must not be applied to the face . N.B. As any other corticosteroid preparations, Cutacort shouldn’t be used except under medical supervision. Dosage & administration:
Unless otherwise instructed by the doctor, Cutacort should be applied twice daily to the affected areas of skin. In infections of the interdigital spaces it is advisable to place a strip of gauze smeared with Cutacort between the toes or fingers. The treatment with Cutacort must be terminated after regression of the inflammatory or eczematous skin condition, at the latest, however, after 2 weeks, and the therapy continued or followed up with the corticoid- free preparation Cidogen, this applies in particular for use in the inguinal and genital regions. Packing:
Tube of 15 gm. Storage :
Store at a tight room temperature . | 
